Insider Transactions in Q1 2024 at Sotera Health CO (SHC)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2024
|
Warburg Pincus & Co. Director |
SELL
Open market or private sale
|
Indirect |
33,188,726
-15.74%
|
$464,642,164
$14.31 P/Share
|
|
Mar 04
2024
|
Gtcr Investment Xi LLC Director |
SELL
Open market or private sale
|
Indirect |
11,062,908
-15.74%
|
$154,880,712
$14.31 P/Share
|
|
Mar 04
2024
|
Jonathan M. Lyons Sr. Vice President, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
41,124
+25.83%
|
-
|
|
Mar 04
2024
|
Alexander Dimitrief SVP, General Counsel and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
51,405
+15.2%
|
-
|
|
Mar 04
2024
|
Ann R. Klee |
SELL
Open market or private sale
|
Direct |
5,750
-6.22%
|
$80,500
$14.31 P/Share
|
|
Mar 04
2024
|
Michael P Rutz President of Sterigenics |
SELL
Open market or private sale
|
Direct |
83,109
-13.24%
|
$1,163,526
$14.31 P/Share
|
|
Mar 04
2024
|
Michael P Rutz President of Sterigenics |
BUY
Grant, award, or other acquisition
|
Direct |
34,270
+5.18%
|
-
|
|
Mar 04
2024
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Open market or private sale
|
Indirect |
1,003,870
-15.55%
|
$14,054,180
$14.31 P/Share
|
|
Mar 04
2024
|
Michael B. Petras Jr. Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
274,160
+28.15%
|
-
|
|
Mar 02
2024
|
Michael P Rutz President of Sterigenics |
SELL
Payment of exercise price or tax liability
|
Direct |
5,501
-0.46%
|
$77,014
$14.56 P/Share
|
|
Mar 02
2024
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
49,564
-5.36%
|
$693,896
$14.56 P/Share
|